AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NovoCure Ltd Director's Dealing 2021

Mar 4, 2021

31949_dirs_2021-03-04_75e01986-019b-4b42-ae57-0e2a32f00fe0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2021-03-02

Reporting Person: Madden Martin J. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-02	Restricted Share Units	A	111	—	Acquired	418	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	14806	Direct

Footnotes

F1: Represents shares indirectly beneficially owned by Mr. Madden that are held by his child with whom he shares a residence. Mr. Madden disclaims beneficial ownership of these shares.